Skip to main content
  • Novel device successfully closes transcaval access for TAVR in early feasibility study

    A novel device successfully closed transcaval access in the setting of transcatheter aortic valve replacement (TAVR) in all study patients, according to late-breaking trial results presented Tuesday at Cardiovascular Research Technologies (CRT) 2019.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details